Identification of model peptides as affinity ligands for the purification of humanized monoclonal antibodies by means of phage display

被引:45
作者
Ehrlich, GK [1 ]
Bailon, P [1 ]
机构
[1] Hoffmann La Roche Inc, Pharmaceut & Analyt R&D, Nutley, NJ 07110 USA
来源
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS | 2001年 / 49卷 / 1-3期
关键词
phage display; biopanning; affinity chromatography; bioinformatics; peptide; peptidomimetics; protein A; immunoglobulin G; binding domain; molecular modeling;
D O I
10.1016/S0165-022X(01)00212-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A proof-of-principle study was initiated to determine whether phage-display technology could be used to identify peptides as leads in the customization of ligands for affinity chromatography and to identify a peptide or peptidomimetic for use as a Protein A alternative in the affinity purification of monoclonal antibodies. The constant region of humanized anti-Tac (HAT), prepared by pepsin digestion and receptor-affinity chromatography, was used as the target for phage display in this study. As such, 20 phage-derived peptide sequences were identified from four rounds of biopanning with two linear phage-display libraries (7-mer, containing 100 copies of 2 x 10(9) sequences and 12-mer, containing 70 copies of 1.4 x 109 sequences). Five peptides were synthesized for use as affinity ligands, based on sequence homology to Protein A, sequence redundancy, and amino acid motifs. The best HAT binding immobilized peptide was EPIHRSTL-TALL. The best-fit analysis of this peptide sequence with Protein A yielded an alignment well within the Fc binding domain of Protein A. These results suggest that phage display can sme as a tool in the identification of peptides as model ligands for affinity chromatography. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:443 / 454
页数:12
相关论文
共 28 条
[1]   RECEPTOR-AFFINITY CHROMATOGRAPHY [J].
BAILON, P ;
WEBER, DV .
NATURE, 1988, 335 (6193) :839-840
[2]   RECEPTOR-AFFINITY CHROMATOGRAPHY - A ONE-STEP PURIFICATION FOR RECOMBINANT INTERLEUKIN-2 [J].
BAILON, P ;
WEBER, DV ;
KEENEY, RF ;
FREDERICKS, JE ;
SMITH, C ;
FAMILLETTI, PC ;
SMART, JE .
BIO-TECHNOLOGY, 1987, 5 (11) :1195-1198
[3]   Minimizing a binding domain from protein A [J].
Braisted, AC ;
Wells, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5688-5692
[4]  
Ehrlich GK, 2000, METHODS MOL BIOL, V147, P195
[5]  
Ehrlich GK, 1998, J MOL RECOGNIT, V11, P121, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<121::AID-JMR406>3.0.CO
[6]  
2-Z
[7]  
Fassina G, 1998, J MOL RECOGNIT, V11, P128, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<128::AID-JMR408>3.0.CO
[8]  
2-8
[9]   3-DIMENSIONAL SOLUTION STRUCTURE OF THE B-DOMAIN OF STAPHYLOCOCCAL PROTEIN-A - COMPARISONS OF THE SOLUTION AND CRYSTAL-STRUCTURES [J].
GOUDA, H ;
TORIGOE, H ;
SAITO, A ;
SATO, M ;
ARATA, Y ;
SHIMADA, I .
BIOCHEMISTRY, 1992, 31 (40) :9665-9672
[10]  
Guerrier L, 1998, J MOL RECOGNIT, V11, P107, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<107::AID-JMR401>3.0.CO